文献速递眼底病与葡萄膜炎青光眼神经眼科

2009-2020年以色列失明病因的时间趋势:降低主要失明病因的方法是否已用尽?

Time Trends of Etiologies of Blindness in Israel 2009-2020:Have Methods to Decrease Leading Causes of Blindness Been Exhausted?
PubMed 文献 · Am J Ophthalmol · 2022-03-12

该研究基于以色列国家盲人登记处2009-2020年数据,描述性回顾性分析法定失明新发病例的病因趋势,并与前十年比较。年龄标化失明发病率从2009年每10万居民15.76降至2020年11.83,下降24.9%;年均下降至2013年明显(P < .001,6.15%),此后趋于平缓(P = .71,0.42%)。年龄相关性黄斑变性、青光眼、视神经萎缩和白内障至2014年下降后进入平台期;糖尿病视网膜病变发病率整个十年下降(P < .001,9.2%),2014年后下降速度减缓。作者认为以色列多数主要失明病因的防控效果可能已接近饱和。

要点

  • 以色列年龄标化失明发病率从2009年15.76/10万降至2020年11.83/10万,下降24.9%。
  • 年均下降至2013年明显(P < .001,6.15%),此后趋于平缓(P = .71,0.42%)。
  • AMD、青光眼、视神经萎缩和白内障至2014年下降后进入平台期,糖尿病视网膜病变整个十年下降(P < .001,9.2%)。

核心结论

  • 以色列多数主要失明病因(年龄相关性黄斑变性、青光眼和白内障)的防控效果可能已接近饱和;糖尿病视网膜病变发病率维持下降但已观察到减缓;可能需要新的检测和治疗手段才能再次改善。

研究设计与样本

  • 描述性、回顾性、基于人群的趋势研究,数据取自以色列国家盲人登记处2009-2020年,包括人口学、登记年份和病因。

主要发现

  • 以色列年龄标化失明发病率从2009年每10万居民15.76降至2020年11.83,下降24.9%。
  • 年均下降至2013年明显(P < .001,6.15%),此后趋于平缓(P = .71,0.42%)。
  • 年龄相关性黄斑变性、青光眼、视神经萎缩和白内障至2014年下降后进入平台期并维持至研究结束。
  • 糖尿病视网膜病变发病率整个十年下降(P < .001,9.2%),2014年后下降速度减缓。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To perform a nationwide analysis of trends in the incidence of etiologies for legal blindness in Israel during 2009-2020, and to compare the results with those of the previous decade. DESIGN: Descriptive, retrospective population-based trend study. METHODS: Data were retrieved from the Israeli National Registry of the Blind during 2009-2020. Data obtained included demographics, years of registration, and causes. Primary and secondary outcomes were the incidence of new certified blindness cases and its comparison with that of the previous decade, respectively. RESULTS: The age-standardized incidence rate of blindness in Israel decreased from 15.76 per 100,000 residents in 2009 to 11.83 in 2020, a 24.9% drop. The mean annual decline was evident until 2013 (P < .001, 6.15%), but subsequently flattened (P = .71, 0.42%). Age-related macular degeneration (AMD), glaucoma, optic atrophy, and cataract decreased until 2014, and reached a plateau that was maintained until the end of the study period. Diabetic retinopathy (DR) incidence rates diminished throughout the decade (P < .001, 9.2%), with attenuation of the rate of decline after 2014. CONCLUSIONS: The impact of efforts to reduce the incidence of preventable causes of blindness may have nearly reached saturation for most of the leading causes of blindness in Israel, namely, AMD, glaucoma and cataract. The incidence of DR has been maintained; however, attenuation has been observed. New modalities to detect and treat these causes may have to emerge before a resurgence of improvement can occur.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Israeli A, Peer H, Gleitman I, et al. Time Trends of Etiologies of Blindness in Israel 2009-2020:Have Methods to Decrease Leading Causes of Blindness Been Exhausted? Am J Ophthalmol. 2022. PMID: 35288071. doi:10.1016/j.ajo.2022.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。